Related Experiment Video
Updated: Jun 22, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
[Lopinavir/ritonavir monotherapy. Possible indications].
1Unidad de Enfermedades Infecciosas, Hospital La Fe, Valencia, España. jlopezal@medynet.com
Enfermedades Infecciosas Y Microbiologia Clinica
|July 3, 2009
Summary
Lopinavir/ritonavir (LPV/r) monotherapy effectively maintains viral suppression in patients simplifying antiretroviral therapy. This strategy offers reduced toxicity and cost benefits for compliant individuals.
Area of Science:
- Infectious Diseases
- Virology
- Pharmacology
Context:
- Antiretroviral therapy (ART) simplification is crucial for long-term HIV management.
- Maintaining viral suppression is key to preventing disease progression and transmission.
- Nucleoside analog toxicity and co-morbidities necessitate alternative ART strategies.
Purpose:
- To evaluate lopinavir/ritonavir (LPV/r) monotherapy as a simplification strategy for HIV patients with sustained undetectable viral loads.
- To assess the efficacy of LPV/r monotherapy in maintaining viral replication blockade.
- To determine the suitability of LPV/r monotherapy for patients experiencing nucleoside analog toxicity or co-morbidities.
Summary:
- Monotherapy with LPV/r demonstrated sustained viral replication blockade in patients simplifying ART.
- The strategy is recommended for patients with at least 6 months of undetectable viral load and high adherence.
- LPV/r monotherapy is a viable option for patients with nucleoside analog-related toxicities, co-morbidities, or those preferring a reduced pill burden.
Impact:
- Simplifying ART with LPV/r monotherapy reduces treatment toxicity and healthcare costs.
- This approach maintains treatment efficacy without compromising future therapeutic options.
- It provides a valuable alternative for specific patient populations, enhancing adherence and quality of life.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...